Habilita, Ospedale di Sarnico
Sarnico, Bergamo, 24067, Italy
NCT Number: NCT01926522
The investigators evaluated the effectiveness of the application of analysing treadmill, muscle strengthening and balance training compared to a control intervention in patients with diabetic neuropathy.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Sarnico, Bergamo, 24067, Italy
Recent studies witnessed how physical exercise may interrupt the devastating decrease of muscle performance in DSP and further experiments are underway to find more exercises for the recovery of motor function impairment. In fact the rehabilitation treatment, that aims at reducing motor disability, preserving gait functions and preventing falling risks, is an interesting therapeutic approach. Literature recommends balance re-training exercises, muscle strengthening, selective stretching and retraining of motor activity.
New technologies produced in the recent decades different devices used in strengthening exercises (electromechanical dynamometers), balance recovery (balance platforms) and gait (analyzing treadmills) have visual feedbacks through which the patients may independently monitor accuracy and intensity of their exercises, being therefore strongly motivated and resulting in a high training intensity. These technologies are often used in rehabilitation of different patients, but are rarely employed for DSP.
The purpose of this case control study was to examine the effectiveness of the application of analysing treadmill, muscle strengthening and balance training compared to a control intervention in patients with diabetic neuropathy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The length of stride of reference used during the exercise is personalized and depends on the height of patients. Each patient carries out the feedback for 20 minutes with the aim of generating the most symmetric and regular gait.
Patients, with the dynamometer, work on strengthening of flexor and extensor muscles with ankle speeds at 90°/sec and 120°/sec. The strengthening technique was performed twice for 10 minutes each time with a 1 minute rest between sets.
The session ends with a 20-minute feedback on dynamic balance platform by carrying out exercises in which they need to reach randomly appearing targets. Subjects begin with 12 minutes the first 4 sessions, progress to 16 minutes the next 2 sessions, then 18' (2 sessions), and finally 20', if able, during the last 4 sessions.
Other names: Dynamometric isokinetic device: Biodex System 4,, Balance device: Biodex Balance System SD,, Analyzing treadmill: Biodex Gait Trainer 3.
When needed, more than on e therapist are employed in the intervention for safety reasons.
Other names: Manual rehabilitation with the therapist.
Time frame: 1 day after the treatment
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 6-minute walk test (6MWT) is used to assess endurance.
The 6MWT quantifies functional mobility based on the distance in meters traveled in six minutes. This outcome is a measure of endurance and is particularly significant to evaluate the possibility to perform continuative tasks, that are particularly important for the rehabilitation of diabetic patients and are relevant for an autonomous life. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 1 day after the treatment
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 10-metres walking test is used to assess gait speed.
The speed is quantified with the 10-metres walk test (TWT) over the ground. The gait speed measurement is performed over the middle 6 meters of the TWT and patients are asked to walk at their comfortable speed. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 30 days after the treatment
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 6-minute walk test (6MWT) is used to assess endurance.
The 6MWT quantifies functional mobility based on the distance in meters traveled in six minutes. This outcome is a measure of endurance and is particularly significant to evaluate the possibility to perform continuative tasks, that are particularly important for the rehabilitation of diabetic patients and are relevant for an autonomous life. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 30 days after the treatment
All evaluation procedures are performed by the same examiner who was blinded to the aims of the study and to which group the participants are allocated. The 10-metres walking test is used to assess gait speed.
The speed is quantified with the 10-metres walk test (TWT) over the ground. The gait speed measurement is performed over the middle 6 meters of the TWT and patients are asked to walk at their comfortable speed. Subjects are instructed to walk at a comfortable speed and subjects neurological are able to use assistive devices.
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 1 day after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Time frame: 30 days after the treatment
Giovanni Taveggia
Other
Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01821508
Body Weight, Complications of Diabetes Mellitus
São Paulo, Brazil
View Trial DetailsNCT02335931
Arthropathy, Neurogenic, Charcot's Joint
København NV, Denmark
View Trial DetailsNCT03530176
Arterial Occlusive Diseases, Arteriosclerosis
Edmonton, Alberta, Canada
View Trial DetailsNCT02478190
Complications of Diabetes Mellitus, Diabetes Complications
Minneapolis, Minnesota, United States
View Trial Details